Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetterpeer-review

Abstract

Globally, there have been close to 130 million reported cases of coronavirus disease 2019 (COVID-19) as of 2nd April2021, with 2.8 million deaths documented [1]. In order to reduce the risk of mortality associated with COVID19, several drugs have been repurposed for its treatment.
Original languageEnglish
Number of pages6
JournalJournal of Thrombosis and Thrombolysis
Early online date4 Apr 2021
DOIs
Publication statusE-pub ahead of print - 4 Apr 2021

Fingerprint Dive into the research topics of 'Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis'. Together they form a unique fingerprint.

Cite this